PFASs are a widespread contaminant linked to health issues, particularly affecting infants due to their ability to disrupt endocrine functions.
A new screening method called MSI-NACE-MS/MS was developed to efficiently analyze low levels of PFASs, like PFOA and PFOS, in serum using a straightforward extraction process.
This method provides rapid, precise quantification of PFASs in maternal serum samples, highlighting both its utility for monitoring environmental exposure and its implications for maternal health and potential chronic diseases in children.